Higher risk of death and stroke in patients with persistent vs. paroxysmal atrial fibrillation: results from the ROCKET-AF Trial

AIM: Anticoagulation prophylaxis for stroke is recommended for at-risk patients with either persistent or paroxysmal atrial fibrillation (AF). We compared outcomes in patients with persistent vs. paroxysmal AF receiving oral anticoagulation. METHODS AND RESULTS: Patients randomized in the Rivaroxaba...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Eur Heart J
Auteurs principaux: Steinberg, Benjamin A., Hellkamp, Anne S., Lokhnygina, Yuliya, Patel, Manesh R., Breithardt, Günter, Hankey, Graeme J., Becker, Richard C., Singer, Daniel E., Halperin, Jonathan L., Hacke, Werner, Nessel, Christopher C., Berkowitz, Scott D., Mahaffey, Kenneth W., Fox, Keith A.A., Califf, Robert M., Piccini, Jonathan P.
Format: Artigo
Langue:Inglês
Publié: Oxford University Press 2015
Sujets:
Clinical Research
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4313363/
https://ncbi.nlm.nih.gov/pubmed/25209598
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/eurheartj/ehu359
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires